Alpha1,3-L-fucosyltransferase Expression in Developing Human Myeloid Cells. Antigenic, Enzymatic, and MRNA Analyses
Overview
Authors
Affiliations
In an attempt to correlate the cell surface expression of Lex and sialyl-Lex structures in immature and mature myeloid cells with the genes expressing alpha1,3-fucosyltransferase(s) we have examined: 1) the properties of the cellular alpha1,3-fucosyltransferases and the mRNA transcripts corresponding to the five cloned genes, Fuc-TIII, Fuc-TIV, Fuc-TV, Fuc-TVI, and Fuc-TVII, in mature granulocytes and in the myeloid cell line HL-60, before and after dimethyl sulfoxide-induced differentiation and 2) the properties of the alpha1,3-fucosyltransferases expressed in COS-7 cells transfected with plasmids containing Fuc-TIV and Fuc-TVII cDNAs. The previously shown increase in cell surface expression of sialyl-Lex on differentiation of HL-60 cells (Skacel P. O., Edwards A. J., Harrison C. T., and Watkins W. M. (1991) Blood 78, 1452-1460) is accompanied by a sharp fall in expression of Fuc-TIV mRNA and a persistence of expression of Fuc-TVII mRNA. The properties of the alpha1,3-fucosyltransferase expressed in COS-7 cells transfected with Fuc-TIV are consistent with this being the major gene responsible for the expression of Lex in the immature myeloid cells. In Northern blot analyses, no transcripts of Fuc-TIII, Fuc-TV, or Fuc-TVI were detected in total RNA from mature granulocytes or mRNA from HL-60 cells before or after differentiation. In total RNA from mature granulocytes, Fuc-TIV transcripts were only faintly visible, whereas Fuc-TVII transcripts were quite definitely expressed. The specificity properties of Fuc-TVII expressed in COS-7 cells are consistent with this gene being the major candidate alpha1, 3-fucosyltransferase controlling the expression of sialyl-Lex on mature cells. However, Lex continues to be expressed on the surface of mature granulocytes and cell extracts retain the capacity to transfer fucose to non-sialylated acceptor substrates. The question therefore remains as to whether these properties result from the weakly expressed Fuc-TIV gene or whether another alpha1, 3-fucosyltransferase gene remains to be identified.
Zhan L, Chen L, Chen Z Oncol Lett. 2018; 16(1):924-930.
PMID: 29963165 PMC: 6019892. DOI: 10.3892/ol.2018.8738.
Desiderio V, Papagerakis P, Tirino V, Zheng L, Matossian M, Prince M Oncotarget. 2014; 6(1):71-84.
PMID: 25428916 PMC: 4381579. DOI: 10.18632/oncotarget.2698.
Zandberg W, Kumarasamy J, Pinto B, Vocadlo D J Biol Chem. 2012; 287(47):40021-30.
PMID: 23019334 PMC: 3501042. DOI: 10.1074/jbc.M112.403568.
Barboza M, Pinzon J, Wickramasinghe S, Froehlich J, Moeller I, Smilowitz J Mol Cell Proteomics. 2012; 11(6):M111.015248.
PMID: 22261723 PMC: 3433903. DOI: 10.1074/mcp.M111.015248.
Marathe D, Chandrasekaran E, Lau J, Matta K, Neelamegham S FASEB J. 2008; 22(12):4154-67.
PMID: 18716032 PMC: 2614605. DOI: 10.1096/fj.07-104257.